HUP0200655A2 - Osanetant alkalmazása kedélyállapot-rendellenességek kezelésére használható gyógyszerek előállítására - Google Patents
Osanetant alkalmazása kedélyállapot-rendellenességek kezelésére használható gyógyszerek előállításáraInfo
- Publication number
- HUP0200655A2 HUP0200655A2 HU0200655A HUP0200655A HUP0200655A2 HU P0200655 A2 HUP0200655 A2 HU P0200655A2 HU 0200655 A HU0200655 A HU 0200655A HU P0200655 A HUP0200655 A HU P0200655A HU P0200655 A2 HUP0200655 A2 HU P0200655A2
- Authority
- HU
- Hungary
- Prior art keywords
- osanetant
- production
- mood disorders
- medicaments used
- treat mood
- Prior art date
Links
- 208000019022 Mood disease Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- DZOJBGLFWINFBF-UMSFTDKQSA-N osanetant Chemical compound C([C@](C1)(CCCN2CCC(CC2)(N(C(C)=O)C)C=2C=CC=CC=2)C=2C=C(Cl)C(Cl)=CC=2)CCN1C(=O)C1=CC=CC=C1 DZOJBGLFWINFBF-UMSFTDKQSA-N 0.000 title 1
- 229950009875 osanetant Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9904699A FR2792199B3 (fr) | 1999-04-13 | 1999-04-13 | Utilisation de l'osanetant pour la preparation de medicaments utiles dans le traitement des troubles de l'humeur |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0200655A2 true HUP0200655A2 (hu) | 2002-07-29 |
HUP0200655A3 HUP0200655A3 (en) | 2002-11-28 |
Family
ID=9544412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0200655A HUP0200655A3 (en) | 1999-04-13 | 2000-04-11 | Use of osanetant in the production of medicaments used to treat mood disorders |
Country Status (24)
Country | Link |
---|---|
US (1) | US6420388B1 (hu) |
EP (1) | EP1175215A2 (hu) |
JP (1) | JP2002541190A (hu) |
KR (1) | KR20010105418A (hu) |
CN (1) | CN1354662A (hu) |
AR (1) | AR023452A1 (hu) |
AU (1) | AU3971600A (hu) |
BR (1) | BR0009704A (hu) |
CA (1) | CA2369638A1 (hu) |
CZ (1) | CZ20013645A3 (hu) |
EE (1) | EE200100527A (hu) |
FR (1) | FR2792199B3 (hu) |
HR (1) | HRP20010741A2 (hu) |
HU (1) | HUP0200655A3 (hu) |
ID (1) | ID30458A (hu) |
IS (1) | IS6098A (hu) |
MX (1) | MXPA01010340A (hu) |
NO (1) | NO20014953L (hu) |
PE (1) | PE20010032A1 (hu) |
PL (1) | PL351554A1 (hu) |
SK (1) | SK14552001A3 (hu) |
TR (1) | TR200102930T2 (hu) |
WO (1) | WO2000061125A2 (hu) |
ZA (1) | ZA200108289B (hu) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001095904A1 (en) * | 2000-06-12 | 2001-12-20 | University Of Rochester | Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist |
WO2005061544A2 (en) * | 2003-12-22 | 2005-07-07 | Glaxo Group Limited | Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
JP2007530591A (ja) * | 2004-03-25 | 2007-11-01 | スミスクライン・ビーチャム・コーポレイション | 双極性障害を治療するための、nk3アンタゴニストの使用 |
EP1867717A4 (en) * | 2005-03-15 | 2008-08-20 | Sumitomo Chemical Co | METHOD FOR REDUCE SYMPTOM CAUSED BY MUTUAL DISORDER |
JP2006320201A (ja) * | 2005-05-17 | 2006-11-30 | Sumitomo Chemical Co Ltd | 気分障害又は関連障害による疾患症状を改善させる方法 |
GB0525662D0 (en) | 2005-12-16 | 2006-01-25 | Glaxo Group Ltd | Immunoglobulins |
EP3915560A1 (en) | 2014-06-25 | 2021-12-01 | Emory University | Methods of managing conditioned fear with neurokinin receptor antagonists |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2719311B1 (fr) | 1994-03-18 | 1998-06-26 | Sanofi Sa | Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic. |
FR2729954B1 (fr) * | 1995-01-30 | 1997-08-01 | Sanofi Sa | Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
FR2738819B1 (fr) * | 1995-09-14 | 1997-12-05 | Sanofi Sa | Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant |
AU4176997A (en) | 1996-09-16 | 1998-04-02 | Warner-Lambert Company | 3-alkyl-3-phenyl-piperidines |
-
1999
- 1999-04-13 FR FR9904699A patent/FR2792199B3/fr not_active Expired - Fee Related
-
2000
- 2000-04-11 ID IDW00200102144A patent/ID30458A/id unknown
- 2000-04-11 JP JP2000610458A patent/JP2002541190A/ja not_active Withdrawn
- 2000-04-11 MX MXPA01010340A patent/MXPA01010340A/es not_active Application Discontinuation
- 2000-04-11 PL PL00351554A patent/PL351554A1/xx not_active Application Discontinuation
- 2000-04-11 EE EEP200100527A patent/EE200100527A/xx unknown
- 2000-04-11 TR TR2001/02930T patent/TR200102930T2/xx unknown
- 2000-04-11 CN CN00806091A patent/CN1354662A/zh active Pending
- 2000-04-11 CZ CZ20013645A patent/CZ20013645A3/cs unknown
- 2000-04-11 BR BR0009704-7A patent/BR0009704A/pt not_active Application Discontinuation
- 2000-04-11 EP EP00918941A patent/EP1175215A2/fr not_active Withdrawn
- 2000-04-11 KR KR1020017012990A patent/KR20010105418A/ko not_active Application Discontinuation
- 2000-04-11 CA CA002369638A patent/CA2369638A1/en not_active Abandoned
- 2000-04-11 SK SK1455-2001A patent/SK14552001A3/sk unknown
- 2000-04-11 HU HU0200655A patent/HUP0200655A3/hu unknown
- 2000-04-11 WO PCT/FR2000/000924 patent/WO2000061125A2/fr not_active Application Discontinuation
- 2000-04-11 US US09/958,266 patent/US6420388B1/en not_active Expired - Fee Related
- 2000-04-11 AU AU39716/00A patent/AU3971600A/en not_active Abandoned
- 2000-04-12 AR ARP000101670A patent/AR023452A1/es unknown
- 2000-04-13 PE PE2000000343A patent/PE20010032A1/es not_active Application Discontinuation
-
2001
- 2001-09-28 IS IS6098A patent/IS6098A/is unknown
- 2001-10-09 ZA ZA200108289A patent/ZA200108289B/xx unknown
- 2001-10-11 NO NO20014953A patent/NO20014953L/no not_active Application Discontinuation
- 2001-10-12 HR HR20010741A patent/HRP20010741A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1175215A2 (fr) | 2002-01-30 |
PL351554A1 (en) | 2003-05-05 |
TR200102930T2 (tr) | 2002-04-22 |
CZ20013645A3 (cs) | 2002-01-16 |
NO20014953L (no) | 2001-12-11 |
NO20014953D0 (no) | 2001-10-11 |
US6420388B1 (en) | 2002-07-16 |
AU3971600A (en) | 2000-11-14 |
FR2792199A1 (fr) | 2000-10-20 |
EE200100527A (et) | 2002-12-16 |
IS6098A (is) | 2001-09-28 |
ZA200108289B (en) | 2002-12-24 |
SK14552001A3 (sk) | 2002-02-05 |
AR023452A1 (es) | 2002-09-04 |
CA2369638A1 (en) | 2000-10-19 |
PE20010032A1 (es) | 2001-04-11 |
JP2002541190A (ja) | 2002-12-03 |
KR20010105418A (ko) | 2001-11-28 |
FR2792199B3 (fr) | 2001-05-18 |
BR0009704A (pt) | 2002-01-08 |
CN1354662A (zh) | 2002-06-19 |
HUP0200655A3 (en) | 2002-11-28 |
MXPA01010340A (es) | 2002-05-06 |
ID30458A (id) | 2001-12-06 |
WO2000061125A3 (fr) | 2001-04-19 |
WO2000061125A2 (fr) | 2000-10-19 |
HRP20010741A2 (en) | 2002-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0400914A3 (en) | Methods of treatment of mitochondrial disorders | |
GB0007193D0 (en) | Treatment of movrmrnt disorders | |
AU9112201A (en) | Pulmonary delivery in treating disorders of the central nervous system | |
NO20021845D0 (no) | Behandling av sövnforstyrrelser under anvendelse av desloratadin | |
IL127943A (en) | Pharmaceutical and cosmetic compositions for the treatment of skin disorders | |
HK1053058A1 (zh) | 普拉克索用於治療成癮性疾病的用途 | |
IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
AU2001266152A1 (en) | Novel substituted nitrocatechols, their use in the treatment of some central andperipheral nervous system disorders and pharmaceutical compositions containing them | |
AU9527001A (en) | Treatment of T cell disorders | |
HUP0100080A3 (en) | Use of mirtazapine for producing pharmaceutical compositions for treating sleep apneas | |
AU2002215047A1 (en) | Isoquinoline derivatives useful in the treatment of cns disorders | |
HUP0200655A3 (en) | Use of osanetant in the production of medicaments used to treat mood disorders | |
SI1173179T1 (en) | Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent major depressive disorders | |
HUP0200145A3 (en) | Use of tianeptin in the production of medicaments to treat neurodegenerative pathologies | |
HK1049122A1 (en) | The use of mirtazapine for the treatment of sleep disorders | |
HK1057332A1 (en) | Use of 3-benzoylphenylacetic acid derivatives for the treatment of retinal disorders | |
AU2001251306A1 (en) | Treatment of sleep disorders with hypocretin-1 | |
GB0316026D0 (en) | Compositions containing gangliosides for use in the treatment of skin disorders | |
AU4838301A (en) | Treatment of disorders relating to the serotonergic system | |
AU2002210763A1 (en) | Use of 1-ebio in the treatment of bipolar disorders | |
EP1096948A4 (en) | USE OF INTERLEUKIN-11 FOR TREATING GASTROINTESTINAL DISEASES | |
ATA139299A (de) | Verwendung von nikotin zum herstellen von arzneimitteln | |
FI20002612A0 (fi) | Yhdistelmäterapia serotoniinivälityksen häiriöiden hoitamiseksi | |
AU8679801A (en) | Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions | |
GB9916450D0 (en) | Ligands for use in therapeutic compounds for the treatment of hemostasis disorders |